LIVE

/POP Series 1/Rayquaza

Variants

HIGHEST · Conviction 7/10

Rayquaza

POP Series 1 · #3 · Rare

Live NM ask

€11.95

↑ 43.5% 30D

PSA 9

–

no graded data

PSA 10

–

no graded data

Composite

7.4

Cardmarket (EUR) →eBay (US) →

Buy range—Buy range unavailable

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

7.4

SCORE / 10

Liquidity

9.2

Scarcity

9.9

Era potential

8.9

Friction

6.2

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 3.56%Total population

PSA 10

PSA 9

469

PSA 8

589

Total graded

2,415

Gem rate 3.56%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Rayquaza from the POP Series 1 set (#3) currently trades at €41.97 in the raw market. Over the past 30 days the card has appreciated +43.5%. By market value it ranks #3 of 17 in POP Series 1 — the 80th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated medium. Read together, a upper-tier ranking in POP Series 1 alongside rising 30-day momentum frames where Rayquaza sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.